跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anti-angiogenic peptide
首页
药物
anti-angiogenic peptide
anti-angiogenic peptide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-Angiogenic Peptide
申请人: ISTITUTO NAZ PER LA RICERCA SUL CANCRO
优先权: 2004
US
BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DELIVERY OF ANTI-ANGIOGENIC PEPTIDE
申请人: ASCLEPIX THERAPEUTICS INC
优先权: 2017
CN
Therapeutic administration of the scrambled anti-angiogenic peptide C16Y
申请人: US HEALTH
优先权: 2004
US
2 件公开
Anti-angiogenic treatment using VLO4 with a blocking peptide
申请人: CALIFORNIA NORTHSTATE COLLEGE OF PHARMACY LLC
优先权: 2022
US
Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
申请人: INST VAISSEAUX ET DU SANG
优先权: 2004
US
Chondroitin sulfate modifier of anti-angiogenic peptide ES2-AF and preparation method and application of cis-platinum loaded by chondroitin sulfate modifier
申请人: UNIV SHANDONG
优先权: 2021
CN
Long lasting anti-angiogenic peptides
申请人: BRIDON DOMINIQUE P
优先权: 2006
US
3 件公开
Long lasting anti-angiogenic peptides
申请人: CONJUCHEM INC
优先权: 2000
US
药物
反馈